Humira Market Forecast 2026–2034: Trends & Insights According to a new report from Intel Market Research, the global Humira market was valued at USD 13,120 million in 2024 and is projected to decline from USD 12,080 million in 2025 to USD 6,902 million by 2032, registering a negative CAGR of -9.0% during the forecast period. The market contraction is primarily driven by patent expirations, rapid biosimilar adoption, pricing pressure from payers and pharmacy benefit managers (PBMs), and increasing competition from alternative biologic and targeted therapies. Despite declining branded product revenues, expanding biosimilar availability is improving patient access to adalimumab therapies worldwide. Download Sample Report https://www.intelmarketresearch.com/download-free-sample/16317/humira-market-market

Electronic Warfare Market Trends, Opportunities, Key Players, Growth Factors, Revenue Analysis, 2024-2035 Roots Analysis recently published a report on the global Electronic Warfare Market growth. With a focus on historical trends, current developments, and future projections, it offers a data-rich foundation for decision-makers, industry participants, and investors. The report includes both macro and micro-level insights, enabling readers to grasp key dynamics across segments, regions, and product categories. Market Size and Forecast Current Market Size:$ 22.52 Billion Future Market Size: $ 44.25 Billion CAGR: 7.79% Market Overview This growth is calculated based on observed trends, actual industry performance, and current developments in product usage and adoption. The study takes into account the challenges faced by key players and the general market structure, while avoiding speculative interpretations. It focuses on providing a clear picture of market performance across different regions and segments. This report supports strategic planning by delivering verified data, cross-segment comparisons, and actionable insights—available in both PDF and spreadsheet formats for ease of integration. Market Scope and Segmentation - Historical Trend: Since 2020 - Forecast Period: Till 2035 - Market Size 2026: $ 22.52 Billion - Market Size 2035: $ 44.25 Billion - CAGR till 2035: 7.79% - Type of Platform • Airborne Electronic Warfare • Naval Electronic Warfare • Ground Electronic Warfare • Space Electronic Warfare - Type of Capability • Electronic Attack • Electronic Protection • Electronic Support • Other capabilities - Type of Technology • Antennas • Anti-Jam Electronic Protection System • Directed Energy Weapon • IR Missile Warning System • Optical Attack Solutions • Other technologies - Type of Product • 2G Antennas • 3G Antennas • 4G Antennas • 5G Antennas • Countermeasure System • Decoy • Directed Energy Weapon • Jammers • Other products - Type of Frequency • High Frequency • Microwave • Ultra-High Frequency - End Use Industry • Commercial Sector • Military/Defense Sector - Type of Enterprise • Large Enterprises • Small and Medium Enterprises - Geographical Regions • North America ◦ US ◦ Canada ◦ Mexico ◦ Other North American countries • Europe ◦ Austria ◦ Belgium ◦ Denmark ◦ France ◦ Germany ◦ Ireland ◦ Italy ◦ Netherlands ◦ Norway ◦ Russia ◦ Spain ◦ Sweden ◦ Switzerland ◦ UK ◦ Other European countries • Asia ◦ China ◦ India ◦ Japan ◦ Singapore ◦ South Korea ◦ Other Asian countries • Latin America ◦ Brazil ◦ Chile ◦ Colombia ◦ Venezuela ◦ Other Latin American countries • Middle East and North Africa ◦ Egypt ◦ Iran ◦ Iraq ◦ Israel ◦ Kuwait ◦ Saudi Arabia ◦ UAE ◦ Other MENA countries • Rest of the World ◦ Australia ◦ New Zealand ◦ Other countries - Key Players Profiled • BAE Systems • Boeing • Cobham • Collins Aerospace • Elbit Systems • General Dynamics • Harris • HENSOLDT • Israel Aerospace • L3Harris Technologies • Leonardo • Lockheed Martin • Mercury Systems • Moog • Northrop Grumman • Raytheon Technologies • Rheinmetall • Rockwell Collins • Rohde & Schwarz • Saab • Tata Power • Teledyne Technologies • Textron • Thales - PowerPoint Presentation (Complimentary): Available - Customization Scope: 15% Free Customization - Excel Data Packs (Complimentary) • Competitive Landscape • Company Competitiveness Analysis • Patent Analysis • Funding Analysis • Recent Developments • Market Forecast and Opportunity Analysis Read More: https://www.rootsanalysis.com/electronic-warfare-market

Roots Analysis recently published a report on the global GLP-1 Receptor Agonist MarketSize, Share, Trends, Industry Analysis Report growth. With a focus on historical trends, current developments, and future projections, it offers a data-rich foundation for decision-makers, industry participants, and investors. The report includes both macro and micro-level insights, enabling readers to grasp key dynamics across segments, regions, and product categories. Market Size and Forecast Current Market Size: 101.4 billion Future Market Size: USD 180 billion CAGR: 6.6% Market Overview This growth is calculated based on observed trends, actual industry performance, and current developments in product usage and adoption. The study takes into account the challenges faced by key players and the general market structure, while avoiding speculative interpretations. It focuses on providing a clear picture of market performance across different regions and segments. This report supports strategic planning by delivering verified data, cross-segment comparisons, and actionable insights—available in both PDF and spreadsheet formats for ease of integration. Market Scope and Segmentation Historical Trend Since 2020 Forecast Period Till 2035 Market Size 2026 USD 101.4 Billion Market Size 2035 USD 180 Billion CAGR (Till 2035) 6.6% -Segments Covered • Type of Molecule • Active Compound Used • Type of GLP-1 Agonist Drugs • GLP-1 Agonist • Target Indication • Geographical Regions -Key Players Profiled • AstraZeneca • Biolingus • Boehringer Ingelheim • D&D Pharmatech • Eli Lilly • Gmax Biopharm • Hanmi Pharmaceutical • Innogen • Novo Nordisk • PegBio • Pfizer • QL Biopharma • Roche • Sanofi • Sciwind Biosciences • Tonghua Dongbao Pharmaceutical • Viking Therapeutics • Vivani • vTv Therapeutic (A complete list of companies captured is available in the report) -PowerPoint Presentation (Complimentary) Available -Customization Scope 15% Free Customization -Excel Data Packs (Complimentary) -Market Landscape Analysis • Partnerships and Collaborations • Company Competitiveness Analysis • Funding • Clinical Trial Analysis • Demand Analysis • Pricing Analysis • Patent Analysis • Market Size and Opportunity Analysis Read More: https://www.rootsanalysis.com/reports/glp-1-market.html By Region  North America  US  Canada  Mexico  Europe  France  Germany  Italy  Spain  UK  Rest of Europe  Asia-Pacific  China  India  Japan  South Korea  New Zealand  Rest of the Asia-Pacific  Latin America  Argentina  Brazil This segmentation structure provides a clear framework for understanding market dynamics, segment-specific trends, and growth opportunities. Technological and Strategic Insights The Roots Analysis report includes a detailed assessment of: • Technological advancements and R&D activity • Innovations in formulation and delivery methods • Marketing and distribution strategies • Pricing models and cost structures • Manufacturing capacities and supply chain trends These insights are presented neutrally, supported by empirical evidence and primary research validation. Each Player profiled highlights: • Product portfolio and focus areas • Operational footprint and regional presence • Financial and strategic performance • Recent developments (e.g., partnerships, market entries, acquisitions) Regional Insights Each region is analyzed based on: • Historical and current market size • Revenue performance • Contribution to global share • Strategic developments and regional trends Comparative insights across regions enable targeted market entry and expansion strategies. Report Structure • Part 01: Market Overview • Part 02: Market Size, by Regions • Part 03: Market Revenue, by Countries • Part 04: Market Competition, by Key Players • Part 05: Company Profiles

IP Trailblazers 2026: Leading Patent Professionals Driving Strategic IP Excellence Also Read :- https://theciotimes.com/magazine/IP-Trailblazers-2026-Leading-Patent-Professional-Driving-Strategic-IP-Excellence/ Also Read : -https://theciotimes.com/jeffrey-whittle/ #JeffreyWhittle #CioTimes #Leadership #Innovation #BusinessInsights #TechTrends #Entrepreneurship #SuccessStories #DigitalTransformation #IndustryLeaders #Inspiration #Networking #CIO #TechTalk #BusinessStrategy

IP Trailblazers 2026: Leading Patent Professionals Driving Strategic IP Excellence Also Read :- https://theciotimes.com/magazine/IP-Trailblazers-2026-Leading-Patent-Professional-Driving-Strategic-IP-Excellence/ Also Read : -https://theciotimes.com/jeffrey-whittle/ #JeffreyWhittle #CioTimes #Leadership #Innovation #BusinessInsights #TechTrends #Entrepreneurship #SuccessStories #DigitalTransformation #IndustryLeaders #Inspiration #Networking #CIO #TechTalk #BusinessStrategy

Top Intellectual Property Services for Strong Business Protection Protect your business ideas, innovations, and brand identity with expert intellectual property services. From trademarks and patents to copyrights and legal guidance, discover how the right IP protection helps secure long-term business growth and prevents costly disputes. Read more.

Global Wireless Protocol Analyzer Market size was valued at USD 1.19 billion in 2025. The market is projected to grow from USD 1.28 billion in 2026 to USD 2.32 billion by 2034, exhibiting a CAGR of 8.9% during the forecast period. Wireless Protocol Analyzer Market is a specialized diagnostic tool designed to capture, decode, and analyze data packets transmitted across wireless networks such as Wi-Fi, Bluetooth, LTE/5G, and IoT protocols. These devices enable network engineers to troubleshoot connectivity issues, optimize performance metrics like latency and throughput, and ensure compliance with communication standards critical for industries ranging from telecom to automotive electronics. The market growth is driven by escalating demand for network optimization amid rising IoT deployments, which reached 15 billion connected devices globally in 2023. Additionally, advancements in multi-band analyzers capable of handling 6GHz Wi-Fi 6E and millimeter-wave 5G frequencies are accelerating adoption. Key players like Keysight Technologies and Rohde & Schwarz dominate the sector, leveraging patented signal-processing algorithms to maintain competitive edges in this high-margin instrumentation segment. Global Wireless Protocol Analyzer Market size was valued at USD 1.19 billion in 2025. The market is projected to grow from USD 1.28 billion in 2026 to USD 2.32 billion by 2034, exhibiting a CAGR of 8.9% during the forecast period. Wireless Protocol Analyzer Market is a specialized diagnostic tool designed to capture, decode, and analyze data packets transmitted across wireless networks such as Wi-Fi, Bluetooth, LTE/5G, and IoT protocols. These devices enable network engineers to troubleshoot connectivity issues, optimize performance metrics like latency and throughput, and ensure compliance with communication standards critical for industries ranging from telecom to automotive electronics. The market growth is driven by escalating demand for network optimization amid rising IoT deployments, which reached 15 billion connected devices globally in 2023. Additionally, advancements in multi-band analyzers capable of handling 6GHz Wi-Fi 6E and millimeter-wave 5G frequencies are accelerating adoption. Key players like Keysight Technologies and Rohde & Schwarz dominate the sector, leveraging patented signal-processing algorithms to maintain competitive edges in this high-margin instrumentation segment. https://semiconductorinsight.com/report/wireless-protocol-analyzer-market/

Why North America leading Tadalafil API via 26% US$191.78M healthcare infrastructure? Tadalafil APIs form the critical active pharmaceutical ingredient used in both branded and generic PDE5 inhibitor medications. Their extended duration of pharmacological action compared to similar compounds makes them particularly valuable in therapeutic applications. As patent expirations accelerate generic competition, pharmaceutical manufacturers worldwide are expanding their API procurement strategies to meet growing formulation demand. Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/285171/regional-tadalafil-api-forecast-supply-dem-analysis-competitive-market-2025-2032-143

Global Generic Oncology Drugs Market Size & Growth Drivers Through 2034 According to a newly published market research report by 24LifeSciences, global generic oncology drugs market is valued at USD 35.2 billion in 2026 and is projected to reach USD 54.1 billion by 2034, growing at a compound annual growth rate (CAGR) of 6.3% during the forecast period. Generic oncology drugs are bioequivalent versions of brand-name cancer medications used after patent expirations, providing the same active ingredients, dosage, strength, and administration routes as their innovators. These drugs are broadly categorized into small molecule drugs and large molecule drugs (biosimilars), playing a critical role in making cancer treatment affordable and accessible globally. Their established efficacy and cost-effectiveness continue to underpin their importance in oncology care, particularly amid rising healthcare cost pressures. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/8833/generic-oncology-drugs-market

Generic Oncology Drugs Market’s CAGR of 6.3%: Leading Companies to Watch in 2026 According to a newly published market research report by 24LifeSciences, global generic oncology drugs market is valued at USD 35.2 billion in 2026 and is projected to reach USD 54.1 billion by 2034, growing at a compound annual growth rate (CAGR) of 6.3% during the forecast period. Generic oncology drugs are bioequivalent versions of brand-name cancer medications used after patent expirations, providing the same active ingredients, dosage, strength, and administration routes as their innovators. These drugs are broadly categorized into small molecule drugs and large molecule drugs (biosimilars), playing a critical role in making cancer treatment affordable and accessible globally. Their established efficacy and cost-effectiveness continue to underpin their importance in oncology care, particularly amid rising healthcare cost pressures. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/8833/generic-oncology-drugs-market